Clinical Trials Directory — Find Research Studies

Recruiting

A Single-Arm Clinical Trial of Percutaneous Splenic Ablation Combined With Splenic Artery Occlu...

Conditions: Secondary Hypersplenism

Tianjin Medical University Cancer Institute & Hospital...

View details

Recruiting

Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therap...

Conditions: Neoadjuvant Immunotherapy

The Second Hospital of Tianjin Medical University Tianj...

View details

Active Not Recruiting

Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal...

Conditions: Renal Cell Carcinoma, Kidney Neoplasms, Endophytic Renal Tumor, Postoperative Re...

Tianjin Medical University Second Hospital Tianjin Tian...

View details

Recruiting

Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumor...

Conditions: Thymic Epithelial Tumor

Tianjin Medical University Cancer Institute and Hospita...

View details

Recruiting

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuv...

Conditions: Pancreatic Cancer, Adult

Tianjin Medical University Cancer Institute and Hospita...

View details

Not Yet Recruiting

SYH2095 for Advanced Malignant Tumors: Phase I Study

Conditions: Advanced Malignant Tumors

Tianjin Medical University Cancer Institute and Hospita...

View details

Not Yet Recruiting

META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Anemia (AIHA)

Blood Diseases Hospital, Chinese Academy of Medical Sci...

View details

Not Yet Recruiting

Acupuncture for Heel Pain Syndrome

Conditions: Heel Pain Syndrome

The First Teaching Hospital of Tianjin University of Tr...

View details

Not Yet Recruiting

Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP

Conditions: Immune Thrombocytopenia

Ethics Committee of Blood disease hospital, Chinese Aca...

View details

Not Yet Recruiting

Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(...

Conditions: Multiple Myeloma (MM)

Institute of Hematology and Blood Diseases Hospital Chi...

View details

Recruiting

Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic...

Conditions: Severe Hemophilia A

Institute of Hematology & Blood Diseases Hospital Chine...

View details

Recruiting

CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Conditions: Multiple Myeloma (MM), Multiple Myeloma Light Chain Induced Renal Insufficiency

Institute of Hematology and Blood Diseases Hospital Chi...

View details

Active Not Recruiting

A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-...

Conditions: B-cell Non-Hodgkin Lymphoma

Institute of Hematology and Blood Diseases Hospital ,Ch...

View details

Active Not Recruiting

A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary P...

Conditions: Plasma Cell Leukemia

Institute of Hematology and Blood Diseases Hospital Chi...

View details

Recruiting

CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors

Conditions: Relapsed and Refractory CD5 Hematological Tumors

Hematology Hospital of Chinese Academy of Medical Scien...

View details

Recruiting

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients Wit...

Conditions: Myeloid Malignancy

Institute of Hematology and Blood Diseases Hospital, Ch...

View details

Recruiting

A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treatin...

Conditions: Adult Non-infectious Uveitis

Tianjin Medical University Eye Hospital Tianjin Tianjin...

View details

Recruiting

Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carc...

Conditions: Renal Cell Carcinoma (Kidney Cancer)

Tianjin Medical University Second Hospital Tianjin Tian...

View details

Active Not Recruiting

Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI

Conditions: HCC - Hepatocellular Carcinoma

Tianjin Medical University Cancer Institute and Hospita...

View details

Recruiting

Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Rena...

Conditions: Renal Cell Carcinoma (RCC)

Changyi Quan Tianjin Tianjin Municipality

View details

Active Not Recruiting

Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.

Conditions: Biliary Tract Cancers (BTC)

Tianjin Medical University Cancer Institute and Hospita...

View details

Not Yet Recruiting

Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointest...

Conditions: Postoperative Pain, Postoperative Ileus

Tianjin First Central Hospital Tianjin Tianjin Municipa...

View details

Recruiting

An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therap...

Conditions: Digestive System Malignancies

Patients with esophageal, pancreatic, gastric, or color...

View details

Active Not Recruiting

Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepa...

Conditions: Intrahepatic Cholangiocarcinoma (Icc)

Tianjin Medical University Cancer Institute and Hospita...

View details